Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDrreddyslaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Go long in Dr Reddys Labs on decline: Amit Gupta

      Amit Gupta, Head- Derivatives at ICICI Direct recommends going long in Dr Reddys Laboratories on decline at around Rs 2430-2450 with a target of Rs 2480.

    • Buy Sun Pharma, Dr Reddy's Labs, Lupin: Baliga

      Ambareesh Baliga of Edelweiss Financial Services advises to prefer Sun Pharmaceutical Industries, Dr Reddys Laboratories and Lupin from the pharma space.

    • Book profits in Dr Reddys Laboratories: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may book profits in Dr Reddys Laboratories.

    • Sriram Rathi positive on Dr Reddys Laboratories

      Sriram Rathi of Anand Rathi is positive on Dr Reddys Laboratories. "We are expecting strong results to continue for the company for the next 2-4 quarters," he adds.

    • Buy Syndicate Bank, Dr Reddys Labs, ACC: Sukhani

      Sudarshan Sukhani of s2analytics.com advises buying Syndicate Bank, Dr Reddys Laboratories and ACC.

    • Prefer Lupin, Dr Reddys Labs: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may switch from Dishman Pharma and look at stocks like Lupin or Dr Reddys Laboratories.

    • Buy Rel Comm, L&T, Dr Reddys Lab: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com advises buying Reliance Communications, Larsen and Toubro (L&T) and Dr Reddys Laboratories.

    • Hold Dr Reddys Laboratories, says Aashish Tater

      According to Aashish Tater of fortunewizard.com, the long term investors can hold Dr Reddys Laboratories. The stock may test Rs 2700-2800.

    • Check out: 6 trading stocks for short term gain

      Shardul Kulkarni, Angel Broking advised buying Dr Reddys Laboratories with a target of Rs 2520 and selling Unitech October Future with a stoploss at Rs 17.55.

    • Buy Sun Pharma, Cipla, Dr Reddys Labs: Sudarshan Sukhani

      According to Sudarshan Sukhani of s2analytics.com, pharma stocks look attractive and advises buying Sun Pharmaceutical Industries, Cipla and Dr Reddys Laboratories.

    • Check Out: Super Six stocks for September 18

      Manas Jaiswal, manasjaiswal.com suggests buying Apollo Tyres with a target of Rs 69.50 and ITC with a target of Rs 347.

    • Buy Dr Reddys Laboratories: Ashish Chaturmohta

      Ashish Chaturmohta Of Fortune Equity Brokers recommends buying Dr Reddys Laboratories with a target of Rs 2360 and a stoploss at Rs 2250.

    • Buy Cipla, Lupin, Sun Pharma for long term: Sukhani

      According to Sudarshan Sukhani of s2analytics.com, one may buy Cipla, Lupin, Sun Pharmaceutical and Dr Reddys Laboratories at current level with a long term view.

    • Buy Amara Raja Batteries, Dr Reddys Labs: Sandeep Singal

      Sandeep Singal of Emkay Global Financial Services recommends buying Dr Reddys Laboratories, Amara Raja Batteries and Motherson Sumi Systems.

    • Buy Lupin, Cipla & Dr Reddys Labs: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may buy Lupin, Cipla and Dr Reddys Laboratories.

    • Buy Dr Reddys Labs, Sun Pharma, L&T: Sharmila Joshi

      Sharmila Joshi, Head of Equity at Peerless Securities is of the view that one can buy Dr Reddys Laboratories and Sun Pharmaceutical Industries from the pharma space. "From the capital goods space one can choose L&T over BHEL," she adds.

    • Buy Dr Reddys, Sun Pharma Puts: Sudarshan Sukhani

      According to Sudarshan Sukhani of s2analytics.com, one may buy Dr Reddys Laboratories and Sun Pharmaceutical Industries Put options.

    • Buy Dr Reddys Labs; target Rs 2380: Shardul Kulkarni

      Shardul Kulkarni of Angel Broking recommends buying Dr Reddys Laboratories with a target of Rs 2380 and stoploss at Rs 2175.

    • Trading calls: Buy Dr Reddys, RIL, Jindal Steel

      Here are some trading ideas for today:

    • 6 trading stocks for short term gains

      One can buy Dr Reddys Laboratories at its current price keeping a closing stop loss of Rs 2,150 for a target of Rs 2,350, says Rajesh Jain, Religare Securities.

    • Check Out: Super Six stocks for July 24

      One can sell Federal Bank in the range of Rs 380 to Rs 385. Keep a stop loss above Rs 395 on closing basis. My initial target is around Rs 368 and next logical target is Rs 353 in next 10-15 trading sessions, says Rajeev Agarwal of dynamixresearch.in.

    • Buy Dr Reddys Laboratories: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the opinion that one may buy Dr Reddys Laboratories as the stock seems to be making these new highs.

    • F&O: Buy DRL on dips, sell ONGC, says Hemant Thukral

      There has been open interest in last one week to the tune of 29 percent in Dr Reddys Laboratories, while ONGC has been a disappointment post oil and gas policy. From last four sessions, long positions got unwinded, fresh shorts have also creped in.

    • Go long on Dr Reddys Lab; target Rs 2420: Hemant Thukral

      Hemant Thukral of Aditya Birla Money recommends going long on Dr Reddys Laboratories keeping a stop loss of Rs 2250 and target of Rs 2420.

    • Brokerage Calls: 3 key stocks from 3 key sectors

      Here's what brokerages are recommending for Infosys, Dr Reddy's, Mahindra and Mahindra.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347